Ozempic Face Isnt Unique to GLP-1s The term Ozempic face describes the facial changes that accompany rapid weight loss, but this phenomenon isnt caused by any specific medication
Whilst GLP-1 receptor agonists are not licensed for treating inflammatory diseases, emerging clinical evidence suggests potential benefits in several conditions characterised by chronic inflammation
Alcohol and Vitamin B Deficiency Long-term heavy drinking can lead to a deficiency in vitamin B1 (thiamine) , increasing the risk of developing conditions like Wernicke-Korsakoff syndrome , a serious neurological disorder
doi: 10.4239/wjd.v1.i3.68 47 ZhouQZhangLYDaiMFLiZZouCCLiuH
In peptide medicine, stacking simply means using more than one peptide together to achieve a synergistic effect
Up-and-coming medications such as Retatrutide and Cagrilintide are on the horizon, indicating a potential shift in treating obesity and managing diabetes